Postmenopausal osteoporosis
Clinical trials for Postmenopausal osteoporosis explained in plain language.
Never miss a new study
Get alerted when new Postmenopausal osteoporosis trials appear
Sign up with your email to follow new studies for Postmenopausal osteoporosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new antibody rebuild bone in osteoporosis?
Disease control Not yet recruitingThis phase II trial tests an investigational drug called TST002 in postmenopausal women aged 45 to 80 who have osteoporosis or low bone mass. The study compares three different doses of TST002 against a placebo and an existing osteoporosis drug, denosumab. The main goal is to see…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase 2 • Sponsor: Transcenta Therapeutics (Hangzhou) Co., Ltd. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Skin glow test may reveal hidden fracture risk
Knowledge-focused Not yet recruitingThis study looks at whether a simple, non-invasive skin test can help predict how well osteoporosis medications work. Researchers will measure substances called AGEs in the skin of 240 postmenopausal women starting treatment. The goal is to see if higher AGE levels are linked to …
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Sponsor: Bursa City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC